Login / Signup

Outcomes with lower intensity therapy in TP53-mutated acute myeloid leukemia.

Prajwal C BodduHagop KantarjianFarhad RavandiGuillermo Garcia-ManeroGautam BorthakurMichael AndreeffElias J JabbourChristopher B BentonCourtney D DiNardoMarina KonoplevaNaval DaverKeyur PatelKoichi TakahashiRashmi Kanagal-ShamanaJorge CortesTapan Mahendra Kadia
Published in: Leukemia & lymphoma (2018)
Keyphrases
  • acute myeloid leukemia
  • high intensity
  • allogeneic hematopoietic stem cell transplantation
  • type diabetes
  • stem cells
  • mesenchymal stem cells
  • weight loss
  • glycemic control
  • insulin resistance
  • replacement therapy